NYU Langone Health to adopt new Philips health technology solutions in multi-year partnership directed at patient safety, quality and outcomes 16-11-2023, 22:37

The Metals Company Announces Investor Conference Schedule Through End of 2023 8-09-2023, 20:13

Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical development stage, highly selective third generation RXR nuclear receptor agonist compound, supporting its potential use for prevention and treatment of normal 10-07-2024, 07:00